- Home
- MGTX vs NRK Comparison
MGTX vs NRK Comparison
Compare MGTX & NRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- NRK
- Stock Information
- Founded
- MGTX 2015
- NRK 2002
- Country
- MGTX United States
- NRK United States
- Employees
- MGTX N/A
- NRK N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- NRK Trusts Except Educational Religious and Charitable
- Sector
- MGTX Health Care
- NRK Finance
- Exchange
- MGTX Nasdaq
- NRK Nasdaq
- Market Cap
- MGTX 744.9M
- NRK 884.6M
- IPO Year
- MGTX N/A
- NRK N/A
- Fundamental
- Price
- MGTX $8.48
- NRK $10.23
- Analyst Decision
- MGTX Strong Buy
- NRK
- Analyst Count
- MGTX 3
- NRK 0
- Target Price
- MGTX $25.67
- NRK N/A
- AVG Volume (30 Days)
- MGTX 354.0K
- NRK 187.3K
- Earning Date
- MGTX 11-14-2025
- NRK 01-01-0001
- Dividend Yield
- MGTX N/A
- NRK 4.10%
- EPS Growth
- MGTX N/A
- NRK N/A
- EPS
- MGTX N/A
- NRK N/A
- Revenue
- MGTX $37,917,000.00
- NRK N/A
- Revenue This Year
- MGTX $110.63
- NRK N/A
- Revenue Next Year
- MGTX $212.13
- NRK N/A
- P/E Ratio
- MGTX N/A
- NRK N/A
- Revenue Growth
- MGTX 366.84
- NRK N/A
- 52 Week Low
- MGTX $4.55
- NRK $8.95
- 52 Week High
- MGTX $9.50
- NRK $11.09
- Technical
- Relative Strength Index (RSI)
- MGTX 49.29
- NRK 63.45
- Support Level
- MGTX $8.42
- NRK $10.04
- Resistance Level
- MGTX $9.50
- NRK $10.19
- Average True Range (ATR)
- MGTX 0.61
- NRK 0.08
- MACD
- MGTX -0.06
- NRK -0.00
- Stochastic Oscillator
- MGTX 31.98
- NRK 87.93
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About NRK Nuveen New York AMT-Free Quality Municipal Income Fund
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. Its investment objective is to provide current income exempt from regular federal, New York State, and New York City income taxes and from the federal alternative minimum tax applies to individuals and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.